Supratentorial anaplastic gliomas in adults

The prognostic importance of extent of resection and prior low-grade glioma

View More View Less
  • 1 Departments of Oncology and Clinical Neurological Sciences, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

✓ A retrospective analysis is presented of factors affecting the length of survival of 285 consecutive adults with newly diagnosed biopsy-proven supratentorial anaplastic glioma (188 cases of glioblastoma multiforme, 76 of anaplastic astrocytoma, 11 of anaplastic mixed glioma, and 10 of anaplastic oligodendroglioma) treated at a regional cancer center from July, 1982, through December, 1987. The approach to initial therapy included maximum feasible resection and radiotherapy. The median survival time for all patients was 35 weeks. Multivariate analysis demonstrated that age, duration of symptoms, preirradiation performance status, tumor histology, accessibility to resection, extent of resection, radiotherapy, and prior low-grade glioma were significant independent variables influencing survival. The prognostic importance of age, duration of symptoms, performance status, and tumor histology are already recognized, but three “new” findings are reported. First, patients with anaplastic oligodendroglioma had the longest median survival time (278 weeks). Second, corrected for accessibility and all other variables, patients with gross total resection lived longer than those with partial resection, and patients with any degree of resection lived longer than those who underwent only a biopsy procedure. Third, patients with anaplastic glioma in whom there was a prior history of low-grade glioma lived significantly longer after the diagnosis of anaplastic glioma than did patients in whom the anaplastic glioma apparently arose de novo.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: J. Gregory Cairncross, M.D., London Regional Cancer Centre, 790 Commissioners Road East, London, Ontario N6A 4L6, Canada.
  • 1.

    Burger PC, & Vogel FS: Surgical Pathology of the Nervous System and Its Coverings, ed 2. New York: John Wiley, 1982 Burger PC, Vogel FS: Surgical Pathology of the Nervous System and Its Coverings, ed 2. New York: John Wiley, 1982

    • Search Google Scholar
    • Export Citation
  • 2.

    Burger PC, , Vogel FS, & Green SB, et al: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:11061111, 1985 Burger PC, Vogel FS, Green SB, et al: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106–1111, 1985

    • Search Google Scholar
    • Export Citation
  • 3.

    Cairncross JG, & Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23:360364, 1988 Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23:360–364, 1988

    • Search Google Scholar
    • Export Citation
  • 4.

    Chang HC, , Horton J, & Schoenfield D, et al: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:9971007, 1983 Chang HC, Horton J, Schoenfield D, et al: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:997–1007, 1983

    • Search Google Scholar
    • Export Citation
  • 5.

    Cohadon F, , Aouad N, & Rougier A, et al: Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors. J Neurooncol 3:105111, 1985 Cohadon F, Aouad N, Rougier A, et al: Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors. J Neurooncol 3:105–111, 1985

    • Search Google Scholar
    • Export Citation
  • 6.

    Cooper JS, , Borok TL, & Ransohoff J, et al: Malignant glioma: results of combined modality therapy. JAMA 248:6265, 1982 Cooper JS, Borok TL, Ransohoff J, et al: Malignant glioma: results of combined modality therapy. JAMA 248:62–65, 1982

    • Search Google Scholar
    • Export Citation
  • 7.

    Cox DR: Regression models and life tables. J R Stat Soc (Series B) 34:187220, 1972 Cox DR: Regression models and life tables. J R Stat Soc (Series B) 34:187–220, 1972

    • Search Google Scholar
    • Export Citation
  • 8.

    Cutler SJ, & Ederer F: Maximum utilization of the life table method in analyzing survival. J Chronic Dis 8:699712, 1958 Cutler SJ, Ederer F: Maximum utilization of the life table method in analyzing survival. J Chronic Dis 8:699–712, 1958

    • Search Google Scholar
    • Export Citation
  • 9.

    EORTC Brain Tumor Group: Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. J Neurosurg 55:2731, 1981 EORTC Brain Tumor Group: Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. J Neurosurg 55:27–31, 1981

    • Search Google Scholar
    • Export Citation
  • 10.

    Eyre HJ, , Quagliana JM, & Eltringham JR, et al: Randomized comparisons of radiotherapy and CCNU vs. radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. J Neurooncol 1:171177, 1983 Eyre HJ, Quagliana JM, Eltringham JR, et al: Randomized comparisons of radiotherapy and CCNU vs. radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. J Neurooncol 1:171–177, 1983

    • Search Google Scholar
    • Export Citation
  • 11.

    Garcia DM, , Fulling KH, & Marks JE: The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum. Cancer 55:919927, 1985 Garcia DM, Fulling KH, Marks JE: The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum. Cancer 55:919–927, 1985

    • Search Google Scholar
    • Export Citation
  • 12.

    Green SB, , Byar DP, & Walker MD, et al: Comparisons of carmustine, procarbazine, and high-dose methylpredni-solone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67:121132, 1983 Green SB, Byar DP, Walker MD, et al: Comparisons of carmustine, procarbazine, and high-dose methylpredni-solone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67:121–132, 1983

    • Search Google Scholar
    • Export Citation
  • 13.

    Hirakawa K, , Suzuki K, & Ueda S, et al: Multivariate analysis of factors affecting postoperative survival in malignant astrocytoma. J Neurooncol 2:331340, 1984 Hirakawa K, Suzuki K, Ueda S, et al: Multivariate analysis of factors affecting postoperative survival in malignant astrocytoma. J Neurooncol 2:331–340, 1984

    • Search Google Scholar
    • Export Citation
  • 14.

    Jelsma R, & Bucy PC: Glioblastoma multiforme. Its treatment and some factors effecting survival. Arch Neurol 20:161171, 1969 Jelsma R, Bucy PC: Glioblastoma multiforme. Its treatment and some factors effecting survival. Arch Neurol 20:161–171, 1969

    • Search Google Scholar
    • Export Citation
  • 15.

    Karnofsky DA, & Burchemal JH: The clinical evaluation of chemotherapeutic agents in cancer, in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949, pp 191205 Karnofsky DA, Burchemal JH: The clinical evaluation of chemotherapeutic agents in cancer, in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949, pp 191–205

    • Search Google Scholar
    • Export Citation
  • 16.

    Kernohan JW, & Sayre GP: Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology, 1952 Kernohan JW, Sayre GP: Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology, 1952

    • Search Google Scholar
    • Export Citation
  • 17.

    Kristiansen K, , Hagen S, & Kollevold T, et al: Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47:649652, 1981 Kristiansen K, Hagen S, Kollevold T, et al: Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47:649–652, 1981

    • Search Google Scholar
    • Export Citation
  • 18.

    Levin VA, , Hoffman WF, & Heilbron DC, et al: Prognostic significance of the pretreatment CT scan on time of progression for patients with malignant gliomas. J Neurosurg 52:642647, 1980 Levin VA, Hoffman WF, Heilbron DC, et al: Prognostic significance of the pretreatment CT scan on time of progression for patients with malignant gliomas. J Neurosurg 52:642–647, 1980

    • Search Google Scholar
    • Export Citation
  • 19.

    Nelson DF, , Nelson JS, & Davis DR, et al: Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J Neurooncol 3:99103, 1985 Nelson DF, Nelson JS, Davis DR, et al: Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J Neurooncol 3:99–103, 1985

    • Search Google Scholar
    • Export Citation
  • 20.

    Nelson JS, , Tsukada Y, & Schoenfeld D, et al: Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 52:550554, 1983 Nelson JS, Tsukada Y, Schoenfeld D, et al: Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 52:550–554, 1983

    • Search Google Scholar
    • Export Citation
  • 21.

    Payne DG, , Simpson WJ, & Keen C, et al: Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial. Cancer 50:23012306, 1982 Payne DG, Simpson WJ, Keen C, et al: Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial. Cancer 50:2301–2306, 1982

    • Search Google Scholar
    • Export Citation
  • 22.

    Reeves GI, & Marks GE: Prognostic significance of lesion size for glioblastoma. Radiology 132:469471, 1979 Reeves GI, Marks GE: Prognostic significance of lesion size for glioblastoma. Radiology 132:469–471, 1979

    • Search Google Scholar
    • Export Citation
  • 23.

    Ringertz N: Grading of gliomas. Acta Pathol Microbiol Scand 27:5164, 1950 Ringertz N: Grading of gliomas. Acta Pathol Microbiol Scand 27:51–64, 1950

    • Search Google Scholar
    • Export Citation
  • 24.

    Scanlon PW, & Taylor WF: Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurgery 5:301308, 1979 Scanlon PW, Taylor WF: Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurgery 5:301–308, 1979

    • Search Google Scholar
    • Export Citation
  • 25.

    Scherer HJ: Cerebral astrocytomas and their derivatives. Am J Cancer 40:159198, 1940 Scherer HJ: Cerebral astrocytomas and their derivatives. Am J Cancer 40:159–198, 1940

    • Search Google Scholar
    • Export Citation
  • 26.

    Shapiro WR: Therapy of adult malignant brain tumors: what have the clinical trials taught us? Semin Oncol 13:3845, 1986 Shapiro WR: Therapy of adult malignant brain tumors: what have the clinical trials taught us? Semin Oncol 13:38–45, 1986

    • Search Google Scholar
    • Export Citation
  • 27.

    Stage WS, & Stein JJ: Treatment of malignant astrocytomas. AJR 120:718, 1974 Stage WS, Stein JJ: Treatment of malignant astrocytomas. AJR 120:7–18, 1974

    • Search Google Scholar
    • Export Citation
  • 28.

    Walker MD, , Alexander E Jr, & Hunt WE, et al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:333343, 1978 Walker MD, Alexander E Jr, Hunt WE, et al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:333–343, 1978

    • Search Google Scholar
    • Export Citation
  • 29.

    Walker MD, , Green SB, & Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:13231329, 1980 Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323–1329, 1980

    • Search Google Scholar
    • Export Citation
  • 30.

    Walker MD, , Strike TA, & Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Am J Radiat Oncol Biol Phys 5:17251731, 1979 Walker MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Am J Radiat Oncol Biol Phys 5:1725–1731, 1979

    • Search Google Scholar
    • Export Citation
  • 31.

    Winger MJ, , Macdonald DR, & Schold SC, et al: Malignant glioma at a regional cancer center: implications for the interpretation of clinical trials. Neurology 38 (Suppl 1):213, 1988 (Abstract) Winger MJ, Macdonald DR, Schold SC, et al: Malignant glioma at a regional cancer center: implications for the interpretation of clinical trials. Neurology 38 (Suppl 1):213, 1988 (Abstract)

    • Search Google Scholar
    • Export Citation
  • 32.

    Wood JR, , Green SB, & Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6:338343, 1988 Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6:338–343, 1988

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 531 179 11
Full Text Views 199 10 1
PDF Downloads 114 8 0
EPUB Downloads 0 0 0